Jacob Strahilevitz

9.8k total citations · 3 hit papers
81 papers, 4.8k citations indexed

About

Jacob Strahilevitz is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Jacob Strahilevitz has authored 81 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 26 papers in Infectious Diseases and 26 papers in Molecular Medicine. Recurrent topics in Jacob Strahilevitz's work include Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Infective Endocarditis Diagnosis and Management (13 papers). Jacob Strahilevitz is often cited by papers focused on Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Infective Endocarditis Diagnosis and Management (13 papers). Jacob Strahilevitz collaborates with scholars based in Israel, United States and Australia. Jacob Strahilevitz's co-authors include David C. Hooper, George A. Jacoby, Ari Robicsek, Chi Hye Park, D.F. Sahm, Mark J. Macielag, Darren Abbanat, Karen Bush, Q. C. Truong-Bolduc and Allon E. Moses and has published in prestigious journals such as Circulation, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Jacob Strahilevitz

75 papers receiving 4.7k citations

Hit Papers

Fluoroquinolone-modifying enzyme: a new adaptation of a c... 2005 2026 2012 2019 2005 2009 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
    2005 750 citations Ari Robicsek, Jacob Strahilevitz et al. profile →
  2. Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
    2009 729 citations Jacob Strahilevitz, George A. Jacoby et al. profile →
  3. Vaginal microbiome transplantation in women with intractable bacterial vaginosis
    2019 264 citations Jacob Strahilevitz, Allon E. Moses et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Strahilevitz Israel 29 2.8k 1.3k 1.1k 1.0k 1.0k 81 4.8k
Ferrán Navarro Spain 41 2.9k 1.0× 1.0k 0.8× 1.5k 1.4× 1.0k 1.0× 939 0.9× 147 4.8k
Keigo Shibayama Japan 39 3.0k 1.1× 1.8k 1.4× 1.5k 1.4× 916 0.9× 1.5k 1.4× 228 6.1k
Yin-Ching Chuang Taiwan 43 2.3k 0.8× 1.6k 1.2× 1.4k 1.3× 1.1k 1.0× 837 0.8× 179 5.8k
David W. Wareham United Kingdom 38 2.9k 1.0× 889 0.7× 1.1k 1.0× 480 0.5× 963 0.9× 103 4.2k
N.J. Legakis Greece 40 2.6k 0.9× 1.5k 1.1× 1.1k 1.0× 973 0.9× 1.1k 1.0× 187 5.1k
Dominique Decré France 33 3.8k 1.4× 1.2k 0.9× 1.9k 1.8× 740 0.7× 902 0.9× 81 4.9k
Hongwei Zhou China 27 4.9k 1.7× 925 0.7× 1.7k 1.6× 860 0.8× 1.4k 1.3× 97 6.8k
D. M. Livermore United Kingdom 22 3.7k 1.3× 1.0k 0.8× 1.3k 1.3× 638 0.6× 1.2k 1.2× 25 4.8k
Patricia Winokur United States 32 1.6k 0.6× 1.5k 1.1× 848 0.8× 850 0.8× 681 0.7× 95 4.0k
Danxia Gu China 15 4.4k 1.6× 661 0.5× 1.5k 1.4× 571 0.5× 1.1k 1.1× 25 5.4k

Countries citing papers authored by Jacob Strahilevitz

Since Specialization
Citations

This map shows the geographic impact of Jacob Strahilevitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Strahilevitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Strahilevitz more than expected).

Fields of papers citing papers by Jacob Strahilevitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Strahilevitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Strahilevitz. The network helps show where Jacob Strahilevitz may publish in the future.

Co-authorship network of co-authors of Jacob Strahilevitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Strahilevitz. A scholar is included among the top collaborators of Jacob Strahilevitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Strahilevitz. Jacob Strahilevitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landman, David, Orit Gefen, Ayelet Michael-Gayego, et al.. (2025). Bactericidal activity of antibiotic combinations against clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus. Journal of Antimicrobial Chemotherapy. 80(6). 1519–1525.
2.
Marano, R, Yonatan Oster, Yair Motro, et al.. (2025). An Omics-Guided Investigation of a Hospital Outbreak Caused by blaNDM-1-Producing Pseudocitrobacter faecalis. The Journal of Infectious Diseases. 232(1). e17–e26. 2 indexed citations
3.
Strahilevitz, Jacob, Yair Motro, Violeta Temper, et al.. (2024). In vivo selection of carbapenem resistance during persistent Klebsiella pneumoniae sequence type 395 bloodstream infection due to OmpK36 deletion. Antimicrobial Agents and Chemotherapy. 68(8). e0066324–e0066324. 1 indexed citations
4.
Duvdevani, Mordechai, et al.. (2023). Timing of midstream urine culture before endourological procedure—can we do better?—A comparative study. Urolithiasis. 51(1). 110–110. 1 indexed citations
5.
Grisariu, Sigal, Mila Rivkin, Polina Stepensky, et al.. (2023). High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients. Clinical Transplantation. 37(11). e15098–e15098. 4 indexed citations
6.
Averbuch, Diana, et al.. (2022). Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria. Microbial Drug Resistance. 28(5). 593–600. 7 indexed citations
7.
Goldstein, Gal, et al.. (2022). Bacteremia in Children with Solid Tumors: Etiology, Antimicrobial Susceptibility, Factors Associated with Multidrug Resistance, and Mortality. Microbial Drug Resistance. 28(5). 601–610. 2 indexed citations
8.
Calderon‐Margalit, Ronit, Jacob Strahilevitz, & Ora Paltiel. (2022). Questioning the justification for a fourth SARS-CoV-2 vaccine. Clinical Microbiology and Infection. 28(7). 905–907. 4 indexed citations
9.
Gefen, Orit, Ronen Fluss, Irit Levin-Reisman, et al.. (2022). Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study. Clinical Infectious Diseases. 75(10). 1706–1713. 15 indexed citations
10.
Shasha, David, et al.. (2014). Visceral Cat Scratch Disease with Endocarditis in an Immunocompetent Adult: A Case Report and Review of the Literature. Vector-Borne and Zoonotic Diseases. 14(3). 175–181. 7 indexed citations
11.
Regev‐Yochay, Gili, Galia Rahav, Jacob Strahilevitz, et al.. (2013). A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7. Vaccine. 31(19). 2387–2394. 11 indexed citations
12.
Alagna, Laura, Bradly P. Nicholson, Jacob Strahilevitz, et al.. (2013). Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis – Prospective Cohort Study. Clinical Microbiology and Infection. 20(6). 566–575. 71 indexed citations
13.
Benenson, Shmuel, Shiri Navon‐Venezia, Yehuda Carmeli, et al.. (2009). Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. International Journal of Infectious Diseases. 13(5). e295–e298. 31 indexed citations
14.
Korem, Maya, et al.. (2008). Changes in aac(6 ′ )-Ib-cr Prevalence and Fluoroquinolone Resistance in Nosocomial Isolates of Escherichia coli Collected from 1991 through 2005. Antimicrobial Agents and Chemotherapy. 53(3). 1268–1270. 25 indexed citations
15.
Strahilevitz, Jacob. (2008). Emergence of aac(6 ' )-Ib-cr as the Predominant Form of Plasmid Mediated Quinolone Resistance (PMQR) in E. coli , 1991-2005. 46th Annual Meeting. 1 indexed citations
16.
Chmelnitsky, Inna, Shiri Navon‐Venezia, Jacob Strahilevitz, & Yehuda Carmeli. (2008). Plasmid-Mediated qnrB2 and Carbapenemase Gene bla KPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates. Antimicrobial Agents and Chemotherapy. 52(8). 2962–2965. 35 indexed citations
17.
Truong-Bolduc, Q. C., Jacob Strahilevitz, & David C. Hooper. (2006). NorC, a New Efflux Pump Regulated by MgrA of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 50(3). 1104–1107. 107 indexed citations
18.
Robicsek, Ari, Jacob Strahilevitz, D.F. Sahm, George A. Jacoby, & David C. Hooper. (2006). qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States. Antimicrobial Agents and Chemotherapy. 50(8). 2872–2874. 477 indexed citations
19.
Strahilevitz, Jacob & David C. Hooper. (2005). Dual Targeting of Topoisomerase IV and Gyrase To Reduce Mutant Selection: Direct Testing of the Paradigm by Using WCK-1734, a New Fluoroquinolone, and Ciprofloxacin. Antimicrobial Agents and Chemotherapy. 49(5). 1949–1956. 44 indexed citations
20.
Polacheck, Itzhack, et al.. (2000). Recovery of Candida dubliniensis from Non-Human Immunodeficiency Virus-Infected Patients in Israel. Journal of Clinical Microbiology. 38(1). 170–174. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferrán Navarro Breakdown of academic impact, for papers by Keigo Shibayama Breakdown of academic impact, for papers by Yin-Ching Chuang Breakdown of academic impact, for papers by David W. Wareham Breakdown of academic impact, for papers by N.J. Legakis Breakdown of academic impact, for papers by Dominique Decré Breakdown of academic impact, for papers by Hongwei Zhou Breakdown of academic impact, for papers by D. M. Livermore Breakdown of academic impact, for papers by Patricia Winokur Breakdown of academic impact, for papers by Danxia Gu
Rankless by CCL
2026